These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 32145868)
1. Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment. Cheung CC; Roston TM; Andrade JG; Bennett MT; Davis MK Can J Cardiol; 2020 Mar; 36(3):416-423. PubMed ID: 32145868 [TBL] [Abstract][Full Text] [Related]
2. Use of Implantable Electronic Devices in Patients With Cardiac Amyloidosis. John RM; Stern DL Can J Cardiol; 2020 Mar; 36(3):408-415. PubMed ID: 32037105 [TBL] [Abstract][Full Text] [Related]
3. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. Falk RH; Rubinow A; Cohen AS J Am Coll Cardiol; 1984 Jan; 3(1):107-13. PubMed ID: 6317729 [TBL] [Abstract][Full Text] [Related]
4. Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis. El-Am EA; Dispenzieri A; Melduni RM; Ammash NM; White RD; Hodge DO; Noseworthy PA; Lin G; Pislaru SV; Egbe AC; Grogan M; Nkomo VT J Am Coll Cardiol; 2019 Feb; 73(5):589-597. PubMed ID: 30732713 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic conduction system disease in cardiac amyloidosis. Mathew V; Olson LJ; Gertz MA; Hayes DL Am J Cardiol; 1997 Dec; 80(11):1491-2. PubMed ID: 9399732 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis. Bukhari S; Khan B J Cardiol; 2023 May; 81(5):429-433. PubMed ID: 36894119 [TBL] [Abstract][Full Text] [Related]
8. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis. Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550 [TBL] [Abstract][Full Text] [Related]
9. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276 [TBL] [Abstract][Full Text] [Related]
10. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
11. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia. Teo WS; Kam R; Tan A Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319 [TBL] [Abstract][Full Text] [Related]
12. Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death. Lin G; Dispenzieri A; Brady PA Eur Heart J; 2010 Jun; 31(12):1538. PubMed ID: 20061577 [No Abstract] [Full Text] [Related]
13. Bradyarrhythmias in Cardiac Amyloidosis and Role of Pacemaker. Bukhari S; Kasi A; Khan B Curr Probl Cardiol; 2023 Nov; 48(11):101912. PubMed ID: 37392977 [TBL] [Abstract][Full Text] [Related]
14. Arrhythmias and Device Therapies in Cardiac Amyloidosis. Bukhari S; Khan SZ; Ghoweba M; Khan B; Bashir Z J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592132 [TBL] [Abstract][Full Text] [Related]